Pennsylvania | 000-00121 | 23-1498399 | ||||||||||||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, Without Par Value | KLIC | The Nasdaq Global Market |
Item 9.01 |
Financial Statements and Exhibits. |
|||||||
(d) | Exhibits. | |||||||
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Inline XBRL for the cover page of this Current Report on Form 8‑K. | |||||||
KULICKE AND SOFFA INDUSTRIES, INC. | |||||||||||
Date: February 4, 2025 | By: | /s/ LESTER WONG | |||||||||
Name: | Lester Wong | ||||||||||
Title: | Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) |
||||||||||
![]() |
Kulicke & Soffa Pte. Ltd.
23A Serangoon North Ave 5
Singapore 554369
+65 6880-9600 main
Co. Regn. No. 199902120H
|
||||
Kulicke and Soffa Industries, Inc.
1005 Virginia Drive
Fort Washington, PA 19034 USA
+1-215-784-6000 main
www.kns.com
|
Quarterly Results - U.S. GAAP | |||||||||||
Fiscal Q1 2025 | Change vs. Fiscal Q1 2024 |
Change vs. Fiscal Q4 2024 |
|||||||||
Net Revenue | $166.1 million | down 3% | down 8.4% | ||||||||
Gross Margin | 52.4% | up 570 bps | up 410 bps | ||||||||
Income from Operations | $86.6 million | up 5018.1% | up 3122.4% | ||||||||
Operating Margin | 52.2% | up 5120 bps | up 5070 bps | ||||||||
Net Income | $81.6 million | up 778.5% | up 573.8% | ||||||||
Net Margin | 49.1% | up 4370 bps | up 4240 bps | ||||||||
EPS – Diluted | $1.51 | up 843.8% | up 586.4% |
Quarterly Results - Non-GAAP | |||||||||||
Fiscal Q1 2025 | Change vs. Fiscal Q1 2024 |
Change vs. Fiscal Q4 2024 |
|||||||||
Income from Operations | $18.9 million | up 73.2% | up 48.8% | ||||||||
Operating Margin | 11.4% | up 500 bps | up 440 bps | ||||||||
Net Income | $20.2 million | up 19.1% | up 9.2% | ||||||||
Net Margin | 12.2% | up 230 bps | up 200 bps | ||||||||
EPS – Diluted | $0.37 | up 23.3% | up 8.8% |
Kulicke and Soffa Industries, Inc. | |||||
Joseph Elgindy | |||||
Finance | |||||
P: +1-215-784-7518 | |||||
Three months ended | |||||||||||
December 28, 2024 | December 30, 2023 | ||||||||||
Net revenue | $ | 166,124 | $ | 171,189 | |||||||
Cost of sales | 79,040 | 91,293 | |||||||||
Gross profit | 87,084 | 79,896 | |||||||||
Operating expenses (income): | |||||||||||
Selling, general and administrative | 36,539 | 40,046 | |||||||||
Research and development | 37,808 | 36,810 | |||||||||
Amortization of intangible assets | 1,246 | 1,347 | |||||||||
Gain relating to cessation of business | (75,987) | — | |||||||||
Restructuring | 829 | — | |||||||||
Total operating expenses | 435 | 78,203 | |||||||||
Income from operations | 86,649 | 1,693 | |||||||||
Other income (expense): | |||||||||||
Interest income | 6,352 | 9,899 | |||||||||
Interest expense | (27) | (22) | |||||||||
Income before income taxes | 92,974 | 11,570 | |||||||||
Income tax expense | 11,332 | 2,277 | |||||||||
Net income | $ | 81,642 | $ | 9,293 | |||||||
Net income per share: | |||||||||||
Basic | $ | 1.52 | $ | 0.16 | |||||||
Diluted | $ | 1.51 | $ | 0.16 | |||||||
Cash dividends declared per share | $ | 0.205 | $ | 0.20 | |||||||
Weighted average shares outstanding: | |||||||||||
Basic | 53,791 | 56,650 | |||||||||
Diluted | 54,212 | 57,023 |
Three months ended | |||||||||||
Supplemental financial data: | December 28, 2024 | December 30, 2023 | |||||||||
Depreciation and amortization | $ | 5,013 | $ | 7,985 | |||||||
Capital expenditures | 2,111 | 3,533 | |||||||||
Equity-based compensation expense: | |||||||||||
Cost of sales | 383 | 359 | |||||||||
Selling, general and administrative | 3,739 | 5,680 | |||||||||
Research and development | 2,019 | 1,818 | |||||||||
Total equity-based compensation expense | $ | 6,141 | $ | 7,857 |
As of | |||||||||||
December 28, 2024 | December 30, 2023 | ||||||||||
Number of employees | 2,702 | 2,981 |
As of | |||||||||||
December 28, 2024 | September 28, 2024 | ||||||||||
ASSETS | |||||||||||
CURRENT ASSETS | |||||||||||
Cash and cash equivalents | $ | 278,325 | $ | 227,147 | |||||||
Short-term investments | 260,000 | 350,000 | |||||||||
Accounts and other receivable, net of allowance for doubtful accounts of $49 and $49, respectively | 247,858 | 193,909 | |||||||||
Inventories, net | 185,060 | 177,736 | |||||||||
Prepaid expenses and other current assets | 42,646 | 46,161 | |||||||||
TOTAL CURRENT ASSETS | 1,013,889 | 994,953 | |||||||||
Property, plant and equipment, net | 62,467 | 64,823 | |||||||||
Operating right-of-use assets | 34,967 | 35,923 | |||||||||
Goodwill | 88,411 | 89,748 | |||||||||
Intangible assets, net | 22,802 | 25,239 | |||||||||
Deferred tax assets | 17,953 | 17,900 | |||||||||
Equity investments | 3,385 | 3,143 | |||||||||
Other assets | 7,571 | 8,433 | |||||||||
TOTAL ASSETS | $ | 1,251,445 | $ | 1,240,162 | |||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||
CURRENT LIABILITIES | |||||||||||
Accounts payable | 48,974 | 58,847 | |||||||||
Operating lease liabilities | 7,048 | 7,718 | |||||||||
Accrued expenses and other current liabilities | 77,073 | 90,802 | |||||||||
Income taxes payable | 36,056 | 26,427 | |||||||||
TOTAL CURRENT LIABILITIES | 169,151 | 183,794 | |||||||||
Deferred tax liabilities | 34,657 | 34,594 | |||||||||
Income taxes payable | 31,546 | 31,352 | |||||||||
Operating lease liabilities | 30,526 | 33,245 | |||||||||
Other liabilities | 12,821 | 13,168 | |||||||||
TOTAL LIABILITIES | 278,701 | 296,153 | |||||||||
SHAREHOLDERS' EQUITY | |||||||||||
Common stock, no par value | 597,901 | 596,703 | |||||||||
Treasury stock, at cost | (914,241) | (881,830) | |||||||||
Retained earnings | 1,313,213 | 1,242,558 | |||||||||
Accumulated other comprehensive loss | (24,129) | (13,422) | |||||||||
TOTAL SHAREHOLDERS' EQUITY | $ | 972,744 | $ | 944,009 | |||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ | 1,251,445 | $ | 1,240,162 |
Three months ended | |||||||||||
December 28, 2024 | December 30, 2023 | ||||||||||
Net cash provided by / (used in) operating activities | $ | 18,902 | $ | (7,331) | |||||||
Net cash provided by / (used in) investing activities | 82,039 | (60,541) | |||||||||
Net cash used in financing activities | (48,452) | (38,124) | |||||||||
Effect of exchange rate changes on cash and cash equivalents | (1,311) | 1,254 | |||||||||
Changes in cash and cash equivalents | 51,178 | (104,742) | |||||||||
Cash and cash equivalents, beginning of period | 227,147 | 529,402 | |||||||||
Cash and cash equivalents, end of period | $ | 278,325 | $ | 424,660 | |||||||
Short-term investments | 260,000 | 285,000 | |||||||||
Total cash, cash equivalents and short-term investments | $ | 538,325 | $ | 709,660 | |||||||
Three months ended | ||||||||||||||||||||
December 28, 2024 | December 30, 2023 | September 28, 2024 | ||||||||||||||||||
Net revenue | $ | 166,124 | $ | 171,189 | 181,319 | |||||||||||||||
U.S. GAAP income from operations | 86,649 | 1,693 | 2,689 | |||||||||||||||||
U.S. GAAP operating margin | 52.2 | % | 1.0 | % | 1.5 | % | ||||||||||||||
Pre-tax non-GAAP items: | ||||||||||||||||||||
Amortization related to intangible assets | 1,246 | 1,347 | 1,266 | |||||||||||||||||
Restructuring | 829 | — | 2,294 | |||||||||||||||||
Equity-based compensation | 6,141 | 7,857 | 6,439 | |||||||||||||||||
Gain relating to cessation of business |
(75,987) | — | — | |||||||||||||||||
Non-GAAP income from operations | $ | 18,878 | $ | 10,897 | $ | 12,688 | ||||||||||||||
Non-GAAP operating margin | 11.4 | % | 6.4 | % | 7.0 | % | ||||||||||||||
Three months ended | ||||||||||||||||||||
December 28, 2024 | December 30, 2023 | September 28, 2024 | ||||||||||||||||||
Net revenue | $ | 166,124 | $ | 171,189 | $ | 181,319 | ||||||||||||||
U.S. GAAP net income | 81,642 | 9,293 | 12,117 | |||||||||||||||||
U.S. GAAP net margin | 49.1 | % | 5.4 | % | 6.7 | % | ||||||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Amortization related to intangible assets | 1,246 | 1,347 | 1,266 | |||||||||||||||||
Restructuring | 829 | — | 2,294 | |||||||||||||||||
Equity-based compensation | 6,141 | 7,857 | 6,439 | |||||||||||||||||
Gain relating to cessation of business | (75,987) | — | — | |||||||||||||||||
Income tax benefit - US one-time transition tax | — | — | (6,461) | |||||||||||||||||
Net income tax expense/(benefit) on non-GAAP items |
6,349 | (1,516) | 2,866 | |||||||||||||||||
Total non-GAAP adjustments | $ | (61,422) | $ | 7,688 | $ | 6,404 | ||||||||||||||
Non-GAAP net income | $ | 20,220 | $ | 16,981 | $ | 18,521 | ||||||||||||||
Non-GAAP net margin | 12.2 | % | 9.9 | % | 10.2 | % | ||||||||||||||
U.S. GAAP net income per share: | ||||||||||||||||||||
Basic | 1.52 | 0.16 | 0.22 | |||||||||||||||||
Diluted(a) |
1.51 | 0.16 | 0.22 | |||||||||||||||||
Non-GAAP adjustments per share:(b) |
||||||||||||||||||||
Basic | (1.14) | 0.14 | 0.12 | |||||||||||||||||
Diluted | (1.14) | 0.14 | 0.12 | |||||||||||||||||
Non-GAAP net income per share: | ||||||||||||||||||||
Basic | 0.38 | 0.30 | 0.34 | |||||||||||||||||
Diluted(c) |
0.37 | 0.30 | 0.34 | |||||||||||||||||
Weighted average shares outstanding: | ||||||||||||||||||||
Basic | 53,791 | 56,650 | 54,368 | |||||||||||||||||
Diluted | 54,212 | 57,023 | 54,871 | |||||||||||||||||
Three months ended | ||||||||||||||||||||
December 28, 2024 | December 30, 2023 | September 28, 2024 | ||||||||||||||||||
U.S. GAAP net cash provided by / (used in) by operating activities | $ | 18,902 | $ | (7,331) | $ | 31,619 | ||||||||||||||
Purchases of property, plant and equipment |
(10,202) | (4,426) | (2,468) | |||||||||||||||||
Proceeds from sales of property, plant and equipment | — | — | 27 | |||||||||||||||||
Non-GAAP adjusted free cash flow | 8,700 | (11,757) | 29,178 | |||||||||||||||||
Second quarter of fiscal 2025 ending March 29, 2025 |
||||||||||||||||||||
GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||
Net revenue |
$165 million
+/- $10 million
|
— |
$165 million
+/- $10 million
|
|||||||||||||||||
Operating expenses |
$79.3 million
+/- 2%
|
$8.8 million B,C,D |
$70.5 million
+/- 2%
|
|||||||||||||||||
Diluted EPS(1) |
$0.03
+/- 10%
|
$0.16 A, B, C, D, E |
$0.19
+/- 10%
|
|||||||||||||||||
Non-GAAP Adjustments | ||||||||||||||||||||
A. Equity-based compensation - Cost of sales |
0.4 | |||||||||||||||||||
B. Equity-based compensation - Selling, general and administrative and Research and development | 6.9 | |||||||||||||||||||
C. Amortization related to intangible assets |
1.4 | |||||||||||||||||||
D. Restructuring expenses | 0.5 | |||||||||||||||||||
E. Net income tax effect of the above items | (0.6) | |||||||||||||||||||